We caught up with Editorial Board member Dr Assaf Hilely (Tel Aviv Medical Center, Tel Aviv, Israel), who talked us through his recent study of non-neovascular age-related macular degeneration with subretinal fluid.
Questions
- What prognostic factors are currently used to guide treatment when initiating anti-vascular endothelial growth factor treatment for patients with age-related macular degeneration (AMD) with and without neovascularisation? (00:07)
- What was the rationale for investigating patterns of subretinal fluid in eyes with AMD without neovascularisation? (01:22)
- Could you tell us a little about the aims and design of your recent study? (02:12)
- What were the findings of the study? (03:20)
- What will be the impact of these findings on clinical practice and what future studies are planned? (04:53)
Speaker Disclosure: Dr Assaf Hilely has no financial or non-financial relationships or activities to declare in relation to this interview.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of ESCRS 2020.
